Close

Aerie (AERI) September volatility at 190 into 'successful' efficacy results of Phase 3 Roclatan trial

Go back to Aerie (AERI) September volatility at 190 into 'successful' efficacy results of Phase 3 Roclatan trial
AERIE PHARMACEUT (NASDAQ: AERI) Delayed: 15.25 --0 (-0%)
Previous Close $15.25    52 Week High $41.72 
Open $15.25    52 Week Low $10.82 
Day High $15.25    P/E N/A 
Day Low $15.25    EPS $-0.95 
Volume 418,332